Exercise Stress ECG Underutilized As Initial Test for Suspected CAD

Share this content:
Exercise Stress ECG Underutilized As Initial Test for Suspected CAD
Exercise Stress ECG Underutilized As Initial Test for Suspected CAD

THURSDAY, Nov. 12, 2015 (HealthDay News) -- Exercise stress electrocardiography (ExECG) can yield substantial data from risk stratification in suspected or known coronary artery disease, according to a state-of-the-art paper published in the Nov. 1 issue of JACC: Cardiovascular Imaging.

Jamieson M. Bourque, M.D., M.H.S., and George A. Beller, M.D., from the University of Virginia Health System in Charlottesville, discuss the value of ExECG for risk stratification of suspected or known coronary artery disease.

The researchers note that variables derived from ExECG can yield considerable data from risk stratification, in addition to or without concurrent stress myocardial imaging. Markers such as ST-segment elevation in lead aVR, abnormal heart rate recovery after exercise, failure to achieve target heart rate, and poor exercise capacity can improve risk stratification of ExECG in addition to exercise-induced ischemic ST-segment depression. The prevalence of inducible ischemia was very low and prognosis excellent for patients achieving ≥10 metabolic equivalents on ExECG. In higher risk populations, cardiac imaging techniques add diagnostic and prognostic value.

"Optimal test selection for symptomatic patients with suspected coronary artery disease requires a patient-centered approach factoring in the risk/benefit ratio and cost-effectiveness," the authors write.

One author disclosed ties to Astellas Global Development.

Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »